Journal of Molecular Neuroscience

, Volume 19, Issue 1, pp 11–16

Synthesis and evaluation of 2-(3′-lodo-4′-aminophenyl)-6-hydroxybenzothiazole for in vivo quantitation of amyloid deposits in alzheimer’s disease

  • Yanming Wang
  • William E. Klunk
  • Guo-Feng Huang
  • Manik L. Debnath
  • Daniel P. Holt
  • Chester A. Mathis
Early Detection Of Cognitive Impairment

DOI: 10.1007/s12031-002-0004-8

Cite this article as:
Wang, Y., Klunk, W.E., Huang, GF. et al. J Mol Neurosci (2002) 19: 11. doi:10.1007/s12031-002-0004-8

Abstract

A potent and brain permeable amyloid ligand has been identified as a lead compound capable of I-123/125-labelling for single photon emission computed tomography (SPECT) imaging. In this study, we report the synthesis and I-125-radiolabelling of Compound 6 and its in vitro and in vivo properties. Compound 6 [2-(3′-iodo-4′-aminophenyl)-6-hydroxybenzothiazole] bound to synthetic Aβ(1–40) fibrils in a saturable manner, exhibiting an affinity (Ki) of 11±1.1 nM in a competitive binding assay using a tritiated thioflavin T analog ([3H]BTA-1) as radioligand. [125I]6 binding to synthetic Aβ(1–40) fibrils fit a single-site model. [125I]6 exhibited several-fold higher binding to homogenates of frontal cortex from post-mortem Alzheimer’s disease brain relative to age-matched control brain homogenates. No difference in binding was observed in cerebellum. The ratio of radioactivity concentration between frontal cortex and cerebellum was 6-fold higher in AD brain homogenates than the age-matched control. [125I]6 also readily penetrated the blood-brain barrier in normal control mice with an average radioactivity concentration of 6.43 ± 0.62%ID/g detected in the whole brain at 2 min post i.v. injection. At 30 min, the radioactivity concentration decreased to 0.40 ± 0.05%ID/g, indicating good clearance in the absence of amyloid deposits in the brain.

Index Entries

Radiopharmaceuticals Alzheimer’s disease amyloid SPECT 

Copyright information

© Humana Press Inc 2002

Authors and Affiliations

  • Yanming Wang
    • 1
  • William E. Klunk
    • 2
  • Guo-Feng Huang
    • 1
  • Manik L. Debnath
    • 2
  • Daniel P. Holt
    • 1
  • Chester A. Mathis
    • 1
  1. 1.PET Facility, Department of Radiology, Western Psychiatric Institute and Clinic, School of MedicineUniversity of PittsburghPittsburgh
  2. 2.Department of Psychiatry, Western Psychiatric Institute and Clinic, School of MedicineUniversity of PittsburghPittsburgh

Personalised recommendations